Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma

BACKGROUND: Currently, the role of immunotherapy in neoadjuvant setting for patients with locally advanced esophageal squamous cell carcinoma (ESCC) is gradually attracting attention. Few studies compared the efficacy of neoadjuvant immunochemotherapy (NICT) and neoadjuvant chemoradiotherapy (NCRT)....

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lei, Wei, Xiu-feng, Li, Can-jun, Yang, Zhao-yang, Yu, Yong-kui, Li, Hao-miao, Xie, Hou-nai, Yang, Ya-fan, Jing, Wei-wei, Wang, Zhen, Kang, Xiao-zheng, Zhang, Rui-xiang, Qin, Jian-jun, Xue, Li-yan, Bi, Nan, Chen, Xian-kai, Li, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713810/
https://www.ncbi.nlm.nih.gov/pubmed/36466925
http://dx.doi.org/10.3389/fimmu.2022.1052542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713810/
https://www.ncbi.nlm.nih.gov/pubmed/36466925
http://dx.doi.org/10.3389/fimmu.2022.1052542

Ejemplares similares